Huntington's Disease News and Research

Latest Huntington's Disease News and Research

Being physical and mental activity delays onset of Huntington’s disease: Research

Being physical and mental activity delays onset of Huntington’s disease: Research

Repligen files IND for Phase 1 study of RG2833 selective HDAC-3 inhibitor for Friedreich's ataxia

Repligen files IND for Phase 1 study of RG2833 selective HDAC-3 inhibitor for Friedreich's ataxia

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Evotec first-quarter operating loss decreases 93% to € 1.5 m

Evotec first-quarter operating loss decreases 93% to € 1.5 m

Neuroscientist Snyder presents annual Ellis S. Grollman Lecture at UMB

Neuroscientist Snyder presents annual Ellis S. Grollman Lecture at UMB

Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

AMRI first-quarter total revenue down 9% to $49.3 million

AMRI first-quarter total revenue down 9% to $49.3 million

Alnylam Biotherapeutics presents new data on RNAi technologies at Cell Culture Engineering XII

Alnylam Biotherapeutics presents new data on RNAi technologies at Cell Culture Engineering XII

Alnylam Pharmaceuticals announces EPO intent to grant notification for patent series covering RNAi therapeutics

Alnylam Pharmaceuticals announces EPO intent to grant notification for patent series covering RNAi therapeutics

Raptor Pharmaceutical presents positive results from Phase 2a trial of DR cysteamine bitartrate for NASH

Raptor Pharmaceutical presents positive results from Phase 2a trial of DR cysteamine bitartrate for NASH

Neuralstem's stem cell treatment for ALS featured on CNN with Dr. Sanjay Gupta

Neuralstem's stem cell treatment for ALS featured on CNN with Dr. Sanjay Gupta

AMRI extends and expands research collaboration with CHDI Foundation

AMRI extends and expands research collaboration with CHDI Foundation

Antidepressants and mood stabilizers may benefit stroke victims

Antidepressants and mood stabilizers may benefit stroke victims

Accumulation of mutated protein may explain damaging cellular behavior in Huntington's disease

Accumulation of mutated protein may explain damaging cellular behavior in Huntington's disease

Raptor Pharmaceutical engages The Trout Group for strategic advisory and investor relations services

Raptor Pharmaceutical engages The Trout Group for strategic advisory and investor relations services

Metabolon awarded U.S. patents for metabolomics methods

Metabolon awarded U.S. patents for metabolomics methods

Higher levels of CRP associated with brain changes: Study

Higher levels of CRP associated with brain changes: Study

Evotec AG reports financial results and corporate updates for 2009

Evotec AG reports financial results and corporate updates for 2009

Neurologix receives US PTO Notice of Allowance concerning treatment approach for epilepsy

Neurologix receives US PTO Notice of Allowance concerning treatment approach for epilepsy

UC Irvine researchers play leading role in genome sequencing of Hydra

UC Irvine researchers play leading role in genome sequencing of Hydra

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.